ストックスクリーナーアプリを入手
4.95
0.40%
-0.02
前日終値:
$4.97
開ける：
$4.96
24時間の取引高:
1.31M
Relative Volume:
1.28
時価総額：
$259.07M
収益：
$44.12M
当期純損益:
$-156.25M
株価収益率:
-1.6124
EPS:
-3.07
ネットキャッシュフロー:
$-154.61M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+90.38%
6か月 パフォーマンス:
+2.91%
1年 パフォーマンス:
-1.20%
1日の値動き範囲:
$4.93
$4.96
1週間の範囲:
$4.93
$4.97
52週間の値動き範囲:
$2.29
$5.90
2 Seventy Bio Inc Stock (TSVT) Company Profile
TSVT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TSVT
2 Seventy Bio Inc
|
4.95 | 259.07M | 44.12M | -156.25M | -154.61M | -3.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-06 | ダウングレード | Goldman | Neutral → Sell |
| 2024-01-31 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-01-31 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-10-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-10-12 | 開始されました | Citigroup | Buy |
| 2023-09-13 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-07-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-31 | 開始されました | Guggenheim | Buy |
| 2022-05-02 | 開始されました | Goldman | Buy |
| 2022-02-10 | 開始されました | SVB Leerink | Outperform |
| 2022-01-06 | 開始されました | Cowen | Outperform |
| 2021-11-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-11-08 | 開始されました | Morgan Stanley | Overweight |
| 2021-11-08 | 開始されました | Wedbush | Outperform |
すべてを表示
2 Seventy Bio Inc (TSVT) 最新ニュース
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Charles Schwab Investment Management Inc. Has $1.26 Million Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
Bristol Meyers Squibb to Acquire 2seventy bio - Contract Pharma
2seventy bio, Inc. (NASDAQ:TSVT) Receives $7.20 Consensus PT from Analysts - Defense World
In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma - Fierce Pharma
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire
Rhumbline Advisers Has $249,000 Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
2Seventy Bio at TD Cowen Conference: Strategic Growth and Challenges - Investing.com
Analysts Set 2seventy bio, Inc. (NASDAQ:TSVT) Target Price at $7.20 - Defense World
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - Business Wire
Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH - Managed Healthcare Executive
Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World
Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World
2 Seventy Bio Inc (TSVT) 財務データ
収益
当期純利益
現金流量
EPS
2 Seventy Bio Inc (TSVT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Baird William D III | President and CEO |
Mar 17 '25 |
Sale |
4.95 |
5,092 |
25,180 |
1,121,034 |
| Eatwell Victoria | Chief Financial Officer |
Mar 17 '25 |
Sale |
4.95 |
2,592 |
12,817 |
444,387 |
| Kynam Global Healthcare Master | 10% Owner |
Mar 11 '25 |
Sale |
4.93 |
11,095,936 |
54,702,964 |
0 |
| Kynam Global Healthcare Master | 10% Owner |
Mar 11 '25 |
Sale |
4.93 |
5,142,111 |
25,350,607 |
0 |
| Snow Jessica | See Remarks |
Jan 06 '25 |
Sale |
2.79 |
5,114 |
14,289 |
147,365 |
| Snow Jessica | See Remarks |
Jan 03 '25 |
Sale |
2.94 |
1,000 |
2,936 |
152,479 |
| Snow Jessica | See Remarks |
Jan 07 '25 |
Sale |
2.64 |
186 |
491 |
147,179 |
| Leschly Nick | Director |
Jan 03 '25 |
Sale |
2.94 |
85,978 |
252,423 |
1,234,498 |
| Leschly Nick | Director |
Jan 06 '25 |
Sale |
2.78 |
892 |
2,478 |
1,233,606 |
| Eatwell Victoria | Chief Financial Officer |
Jan 03 '25 |
Sale |
2.94 |
1,013 |
2,974 |
339,076 |
3.01%
大文字化:
|
ボリューム (24 時間):